Hologic, Inc. (BVMF:H1OL34)

Market Cap	87.88B
Revenue (ttm)	21.91B
Net Income (ttm)	3.02B
Shares Out	n/a
EPS (ttm)	13.30
PE Ratio	29.08
Forward PE	16.30
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1
Average Volume	123
Open	400.00
Previous Close	396.16
Day's Range	400.00 - 400.00
52-Week Range	359.45 - 400.00
Beta	0.71
RSI	53.93
Earnings Date	Nov 3, 2025

About Hologic

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginos...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1985
• Employees: 7,063
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: H1OL34

Financial Performance

In 2025, Hologic's revenue was $4.10 billion, an increase of 1.74% compared to the previous year's $4.03 billion. Earnings were $565.70 million, a decrease of -28.35%.

Financial numbers in USD